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Purpose: Missing data are a potential source of bias in the results of RCTs, but are often 
unavoidable in clinical research, particularly in patient-reported outcome measures (PROMs). 
Maximum likelihood (ML), multiple imputation (MI), and inverse probability weighting (IPW) 
can be used to handle incomplete longitudinal data. This paper compares their performance 
when analyzing PROMs, using a simulation study based on an RCT data set.
Methods: Realistic missing-at-random data were simulated based on patterns observed during 
the follow-up of the knee arthroscopy trial (ISRCTN45837371). Simulation scenarios covered 
different sample sizes, with missing PROM data in 10%–60% of participants. Monotone and 
nonmonotone missing data patterns were considered. Missing data were addressed by using 
ML, MI, and IPW and analyzed via multilevel mixed-effects linear regression models. Root 
mean square errors in the treatment effects were used as performance parameters across 1,000 
simulations.
Results: Nonconvergence issues were observed for IPW at small sample sizes. The performance 
of all three approaches worsened with decreasing sample size and increasing proportions of 
missing data. MI and ML performed similarly when the MI model was restricted to baseline 
variables, but MI performed better when using postrandomization data in the imputation model 
and also in nonmonotone versus monotone missing data scenarios. IPW performed worse than 
ML and MI in all simulation scenarios.
Conclusion: When additional postrandomization information is available, MI can be benefi-
cial over ML for handling incomplete longitudinal PROM data. IPW is not recommended for 
handling missing PROM data in the simulated scenarios. 
Keywords: missing data, repeated measures, patient-reported outcome measures, PROMS, 
multilevel mixed-effects models, multiple imputation, inverse probability weighting
Introduction
Repeated follow-up assessments are common in randomized controlled trials (RCTs).1,2 
The multiple observations obtained from each participant are likely to be more corre-
lated with one another than with the values between different individuals. Appropriate 
statistical analyses, such as mixed-effects linear regression, are needed to handle this 
aspect of longitudinal data.3–5
Although longitudinal data analysis is an important tool in medical research, the 
robustness of its results can be affected by missing data. Longitudinal follow-up data 
can be subject to monotone missingness, where no observations are available for a 
participant after a specific follow-up time point, such as when a patient drops out or 
withdraws from the trial. They can also be affected by intermittent missingness, where 
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missing data points are followed by observed data at later 
follow-ups.6 Often only a small subset of participants from 
a longitudinal data set have follow-up data available at all 
time points.
Patient-reported outcome measures (PROMs) are instru-
ments, often in questionnaire form, which include “any 
report coming directly from patients, without interpretation 
by physicians or others, about how they [the patients] func-
tion or feel in relation to a health condition and its therapy.”7 
Before they are used in research, PROMs undergo rigorous 
testing for validity, reliability, and robustness, to ensure that 
even small relevant changes in health-related quality of life 
can be measured and that measurement differences are not 
due to error or noise.8–11 These characteristics make PROMs 
an important addition to objective measures, which may not 
fully capture the patient experience of a specific treatment or 
disease burden,12 and they are increasingly used in medical 
research. However, PROMs are susceptible to being miss-
ing, particularly in longitudinal follow-up.6,13,14 Missing data 
patterns and mechanisms for PROMs may differ from those 
of clinical and more objective outcomes. 
The literature provides numerous overviews of statistical 
methods to handle longitudinal data with missing observa-
tions.1,6,15–19 Ad hoc missing data methods include deletion 
methods, which discard observations with missing data, and 
single imputation methods, which carry the last observation 
forward.6,16,20,21 These methods are likely to cause bias and 
generate overly precise standard errors (SEs). Although their 
use is generally discouraged, they are commonly used in 
the analysis of all RCTs, including those with longitudinal 
follow-up data.1,2,16,19,22–24
The use of model-based approaches, including maximum 
likelihood (ML) estimation,25 multiple imputation (MI), and 
inverse probability weighting (IPW),26,27 is encouraged. Their 
use is supported by their robust underlying methodology, easy 
implementation in standard statistical software, and use in 
RCT analyses to date.1,2,23
The literature offers few direct comparisons between the 
ML, MI, and IPW approaches for missing data. Guidance on 
best practice is limited, particularly for analyzing PROMs. It 
is important to understand which statistical approaches are 
most appropriate for the analysis of longitudinal RCT data, 
particularly with a focus on PROMs.
Missing data mechanisms
The literature distinguishes between three missing data 
mechanisms. When missing completely at random (MCAR), 
the probability of a value being missing is independent of 
both the observed and unobserved data for this participant. 
When missing at random (MAR), the probability of data 
being missing depends on the values of other observed data, 
but is independent of the values of the missing data. When 
missing not at random (MNAR), the probability that data 
are missing is related to the underlying value of these data, 
and this dependence remains to some extent even when the 
observed data are taken into account. 
Any analysis of MCAR data will produce unbiased 
results. Unbiased results can be obtained for MAR data if 
the analysis approach takes into account the variables related 
to the missing data mechanism. Analyses under an MNAR 
scenario are always biased if based on conventional statistical 
techniques which make MAR assumptions. 
It is impossible to determine the underlying missing data 
mechanism using only observed data. Most approaches for 
handling missing data assume an MAR mechanism, and 
MAR data are used here. However, possible MNAR mecha-
nisms should always be investigated in supporting sensitivity 
analyses, as emphasized later. 
Statistical methods considered in this 
simulation study
The methodology and implementation of ML, MI, and IPW 
are explained briefly here and in detail elsewhere.6,16,24,26–28,30–32 
The ML approach “implicitly impute[s] the unobserved 
data”6 to estimate model parameters.16,28,30 It uses all of the 
observed data for the relevant outcome collected within the 
relevant follow-up, provided that baseline covariate data 
are also available where applicable. Parameter estimates 
are obtained through an iterative process to maximize the 
likelihood of producing the sample data.16 The observed data 
points are used to make inferences about any missing data. 
MI is a common simulation-based technique for handling 
and analyzing missing data. It is generally described as a 
three-step process.24,32 First, an “imputation model” is created, 
which regresses the variable to be imputed on a set of vari-
ables that are predictive of the missing outcome. Imputations 
are drawn at random from the posterior distribution of this 
model. This process is repeated to generate multiple complete 
data sets. Second, each data set is analyzed separately using 
an identical prespecified statistical method. The results of 
these analyses differ only because the imputed observations 
differ. Third, the results are pooled using Rubin’s rule.33 
Including the variation across the imputed data sets reflects 
the uncertainty around the imputed values.6,24,34,35 MI uses all 
of the observed outcome data for the relevant variable and 
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Analyzing incomplete longitudinal PROMs data
MI can be used in cross-sectional settings and to impute 
missing baseline or follow-up data in RCTs and observational 
studies. If several variables include missing observations, 
MI can be applied separately or using an approach such 
as MI by chained equation (MICE), which facilitates the 
simultaneous imputation of several incompletely observed 
variables. In this simulation study, we use MICE to handle 
missing longitudinal data. 
IPW is traditionally used in survey studies. Observations 
with a low probability of being included in the survey are 
given a higher weight in the analysis model to mitigate against 
bias introduced by the sampling design.36,37 However, the 
technique has also gained popularity in the handling of miss-
ing data.26,27,31 The rationale for using IPW in the presence of 
missing data is that the subset of participants with complete 
data for all covariates and follow-up time points, called the 
complete-cases subset, may not be representative of the full 
data set. The complete-cases data subset is analyzed under 
IPW, but the cases are weighted differentially to adjust for the 
bias that would be introduced by a conventional complete-
cases analysis.28 Complete cases that have a low probability 
of being observed due to missing data in comparable par-
ticipants are given a higher weight in the analysis compared 
with those with a high probability of being observed. This 
accounts for the participants who cannot be included in the 
analysis model due to missing data. However, IPW may pro-
duce biased results if a small subgroup of participants has a 
very low probability of having missing data.18
Hypotheses for this work
The three statistical approaches discussed in this paper (ML, 
MI, and IPW) all assume an MAR mechanism, but differ in 
important aspects. Under ML, inferences about missing data 
are restricted to variables contained in the analysis model. 
In contrast, the IPW missingness model and MI imputation 
model are independent from the analysis models and can use 
information from other variables in the data set, including 
postrandomization information. This can make the MAR 
mechanism more plausible38 and may produce less biased 
estimates.37
ML and MI use all of the available follow-up data col-
lected within the relevant time frame for a particular outcome, 
provided that any relevant covariate data are also nonmissing. 
In contrast, some observed data are discarded in IPW, which 
may increase bias and decrease precision around the results.
We hypothesized that MI would produce the best (ie, 
least biased) results when other variables outside the analysis 
model are available to predict missing values. MI and ML 
were expected to perform similarly if the imputation model 
was unable to include variables outside the analysis model 
that were predictive of the missing outcomes. As IPW can 
potentially discard large amounts of available information, 
it was expected to produce inferior results than those of its 
comparators when analyzing RCTs with no more than 1,000 
participants. 
Aims of this research
This research aimed at directly comparing the performances 
of ML, MI, and IPW when handling missing longitudinal 
PROM data in RCT analyses, using simulations based on 
the data from an RCT. The three approaches are all well 
established and can be routinely implemented in standard 
statistical software. The simulation study also aimed at gen-
erating guidance on the most appropriate analysis approach 




This simulation study was based on data collected within the 
knee arthroscopy trial (KAT).40,41 KAT is a large multicenter 
RCT considering the clinical and cost-effectiveness of new 
developments in knee replacements. KAT was designed as 
a partial factorial pragmatic trial. Participants were random-
ized to at least one of four comparisons: patellar resurfacing 
versus no patellar resurfacing; mobile versus fixed bearing; 
all-polyethylene versus metal-backed tibial components; 
and unicompartmental versus total knee replacements. This 
simulation study used data from only the patellar resurfacing 
versus no patellar resurfacing comparison. 
Long-term follow-up of >10 years is ongoing for KAT. 
This simulation study used data over the initial 5-year follow-
up and included only participants with fully observed baseline 
and outcome data. Outcome assessments were performed at 
3 months, 1 year, and yearly thereafter. In total, 983 partici-
pants had completely observed data for the relevant PROM.
Design of the simulation exercise
Figure 1 provides the overview of the simulation study. 
Simulations started with a complete data set (no missing 
data) of the relevant sample size, from which estimates of the 
treatment effects and corresponding SEs were obtained. A 
prespecified proportion of MAR data was then introduced in 
the PROM follow-up data. The different analysis approaches 
were applied to the data set with simulated incomplete 
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estimated from the imputed data sets and compared with the 
“true” estimates obtained from the complete data sets. Here, 
we define “true” estimates as those calculated by using the 
multilevel mixed-effects model before the introduction of 
missing data, ie, the estimates that the various approaches 
for handling missing data aim at replicating. The simulation 
scenarios considered combinations of sample sizes (100, 
250, 500, 750, and 983 participants) and proportions of 
participants with missing follow-up data (10%, 20%, 40%, 
50%, and 60%).
This simulation study aimed at obtaining 1,000 valid 
imputation results for each scenario. The performance of 
the three approaches was measured by the root mean square 
error (RMSE) and mean absolute error (MAE) between 
the “true” and imputed treatment effect estimates, which is 
defined as follows: 


















where N denotes the number of simulations run (1,000 where 
feasible), q the true value for the estimate of interest, and θ̂i 
the estimate of interest obtained from the ith simulation. The 
simulation work was performed in Stata/SE Version 14.39
Instruments
The 5-year follow-up data for a PROM, the Oxford Knee 
Score (OKS), are considered. The OKS assesses pain and 
functional outcomes following knee replacement.42,43 Its 12 
items are combined into a composite score ranging from 0 
to 48, with higher scores indicating higher levels of function 
and less pain. Table 1 shows the mean OKS values observed 
for the participants in each trial arm at each relevant assess-
ment time point.
Missing data simulation
Missing data were introduced into data sets with fully 
observed OKS data of the relevant sample size. For the major-
ity of simulations, mixtures of monotone and intermittently 
missing data, based on the eight most commonly observed 
missing data patterns in the KAT (Table 2), were imposed 
for the relevant proportion of participants. Additional simu-
lations explored monotone missing data patterns, in which 
participants were equally likely to drop out at any of the 
follow-up time points. 
MAR data were simulated using an algorithm proposed 
by van Buuren et al44 and outlined by Yu et al45 and Simons 
et al.46 This algorithm allows researchers to vary the miss-
ing data patterns and the percentage of participants with 
missing data. Figure 2 outlines the steps the implementation 
followed. Missing data were generated for 5%, 10%, 20%, 
30%, 40%, 50%, and 60% of participants. Sample sizes of 
100, 250, 500, and 750 and the maximum sample avail-
able were considered. Smaller sample sizes were obtained 
by sampling the required number of participants from the 
full data set without replacement before simulating the 
missing data. 
Figure 1 Design of the simulation study.
Abbreviations: IPW, inverse probability weighting; MAE, mean absolute error; MAR, missing at random; MI, multiple imputation; ML, maximum likelihood; RMSE, root 
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Analyzing incomplete longitudinal PROMs data
The MAR mechanism was based on logistic regression 
models using baseline variables and follow-up PROM infor-
mation, where relevant, to predict whether participants fell 
into a specific missing data pattern. Explanatory variables 
were randomization allocation, OKS (baseline and follow-up 
where appropriate), age, gender, body mass index, American 
Society of Anesthesiologists’ physical status classification, 
randomizing center size (small/medium/large), postoperative 
complications, and adherence to the randomized procedure. 
The coefficient estimates for each covariate were used in the 
algorithm to generate missing data. 
The effects of a different MAR mechanism were also 
investigated in a “stronger MAR” scenario. The coefficient 
estimates used in the logistic regression model for determin-
ing the probability of participants having missing data were 
changed. The coefficients of covariates outside the analysis 
model were increased threefold, while the coefficients 
included in the analysis model were halved. 
Analysis approaches
The longitudinal PROM data were analyzed using a multilevel 
mixed-effects regression model to compare the PROM over 
time between the two randomization allocations. The statisti-
cal model was based on the analysis prespecified for the KAT 
study. It was adjusted for randomization allocation, baseline 
OKS, gender, age, and follow-up time point (implemented as 
a dummy variable for each year, using the 1-year follow-up 
as the reference category). Nonlinear terms or interactions 
were not used. Although the KAT analysis included interac-
tions between treatment and time,41 they were excluded from 
this simulation because the main focus was estimating the 
overall treatment effect using the three approaches. The model 
included a random intercept and random slope, was fitted 
using an ML approach, and used an unstructured covariance.
The MI and IPW missingness models included all of 
the variables in the analysis model, as well as those used to 
generate the missing data. For exploratory simulations, two 
more PROMs collected in the trial, the EuroQol 5 Dimen-
sion 3 Level questionnaire (EQ-5D-3L)47 and 12-Item Short 
Form Health Survey (SF-12) physical component score,48,49 
were also included. Both were assumed to be fully observed. 
Missing composite scores were replaced with values obtained 
from a single imputation. Imputations for each time point 
were based on relevant baseline data and available OKS, 
SF-12, and EQ-5D follow-up data. The IPW missingness 
model included the composite PROM scores at baseline and 
5-year follow-up. The MI model used all of the baseline and 
follow-up PROM scores. 
Imputations were run separately by treatment arm.24,50 MI 
used MICE and a predictive mean matching approach. For the 
IPW approach, the missingness model was used to estimate 
the probability of missing follow-up data for each participant, 
using a logistic regression model with the outcome variable 
indicating if any follow-up data were missing. The inverse of 
Table 1 Mean OKSs across the follow-up in the subset of participants with completely observed outcome data
Assessment time 
point
No patellar resurfacing Patellar resurfacing Total
n Mean (SD) n Mean (SD) n Mean (SD)
Baseline 492 18.7 (7.4) 491 18.9 (7.3) 983 18.8 (7.3)
3 months 492 31.8 (9.2) 491 32.3 (9.4) 983 32 (9.3)
1 year 492 35.7 (9.7) 491 35.6 (9.5) 983 35.6 (9.6)
2 years 492 36.3 (10) 491 36.2 (10) 983 36.3 (10)
3 years 492 35.6 (10.1) 491 36.1 (9.9) 983 35.9 (10)
4 years 492 34.9 (10.3) 491 35.6 (10.4) 983 35.3 (10.4)
5 years 492 34.9 (10.3) 491 35.6 (10.4) 983 35.3 (10.3)
Abbreviation: OKS, Oxford Knee Score.
Table 2 Longitudinal missing data pattern observed in the case study and imposed on the complete data set
Missingness pattern Total Observed in trial %* % used in simulation Cumulative %
No follow-up data available 62 13.51 22.06 22.06
Only 3-month data missing 49 10.68 17.44 39.50
Only 5-year data missing 46 10.02 16.37 55.87
Data available to year 1 34 7.41 12.10 67.97
Data available to year 2 26 5.66 9.25 77.22
Only 4-year data missing 23 5.01 8.19 85.41
Only 3-year data missing 22 4.79 7.83 93.24
Data available to year 3 19 4.14 6.76 100.00
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Figure 2 Depiction of the algorithm used for each iteration of the simulation of missing PROMs data within the complete-cases data set.
Abbreviations: KAT, knee arthroscopy trial; PROMs, patient-reported outcome measures.
Required:
•  Overall proportion of participants with incomplete data: P
•  Number/type of missing data pattern to be simulated
•  Relative frequency of each missing data pattern (fi)
•  Size of the data set the missing data are imposed on (Ndata set)
Step 1 – assigning missing data pattern
• Assign each participant, at random, to a longitudinal missing data pattern with probability fi
Step 2 – calculation of a linear score
• Calculate a linear score (si) for each participant
The weights for the calculation of si are the regression coefficients from a logistic regression
model predicting the probability of each longitudinal missing data pattern using the covariates
identified to be predictive of missing data in the KAT.
Step 3 – assigning odds
• Within each pattern, cases are split into subgroups based on si
• Odds (Oj) of data being missing in relation to the lowest subgroup are assigned to each
  subgroup
Here, the data are split into three groups of size Nj based on the 33rd and 66th percentiles; 
increasing odds of 1, 2, 3 have been assigned to the groups (as in Yu et al45 and Simons et al46).
Step 4 – calculating the probability of data being missing
• Using Oi and P, the probability of data being missing is calculated.
Here, the following formula introduced by Yu et al45 has been used:
Step 5 – imposing missing data
•  The calculated probability for each participant is compared to a randomly generated
   number (uniform distribution)
•  The observations at the relevant time points are set to be missing in-line with the missing
   data pattern assigned to this participant if the calculated probability exceeds the
   random number
•  Thus, missing data according to the relevant missing data pattern are imposed on the
   complete longitudinal data for the relevant observations
prob (miss) =
Ndataset* Oj * P * fi
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Analyzing incomplete longitudinal PROMs data
this probability was used as the weight in the IPW analysis 
model (subject-specific weight), which used only cases with 
completely observed OKS outcome data.
The MI and IPW approaches were analyzed by using the 
same multilevel mixed-effects regression model described 
above, except that the MI approach analyzed the imputed 
data, and the IPW approach analyzed the complete-cases sub-
set using subject-specific weights to account for missing data. 
The Stata commands “mixed” and “mi impute” were used 
to implement the statistical models.
Ethics approval
Approval for the KAT study was obtained from the Multi-
Research Ethics Committee for Scotland (research protocol 
MREC/98/0/100 – November 1998, ISRCTN45837371) and 
from the Local Research Ethics Committees at each study 
site recruiting participants. All the participants gave written 
informed consent prior to being included in the study. No 
additional ethics approval was required for the performance 
of this simulation study.
Results
In general, the results consistently showed that the RMSE 
(and MAE) increased with increasing proportions of  missing 
data and decreasing sample sizes (Figures 3–5). The graphs 
presented in these figures show the RMSE and SE results, 
while the MAE results are presented in the Supplementary 
materials. For clarity, separate plots are provided for the dif-
ferent proportions of missing data.
Feasibility of the analysis approaches
The ML approach could obtain valid results in all simulation 
scenarios. A negligible proportion of the MI models did not 
converge. Valid results could not be obtained for ∼20% of the 
IPW simulations for a sample size of 100 with 10% missing 
data, ∼3% for a sample size of 100 with 20% missing data, 
and ∼1% for a sample size of 250 with 10% missing data. 
Very low proportions of invalid results were observed for the 
remaining simulations for a sample size of 100.
Performance of the different analysis 
approaches
The first simulation scenario considered the observed patterns 
of missing data. Figure 3 shows the RMSEs introduced into 
the treatment effects. The ML and MI approaches performed 
very similarly, irrespective of the sample size or proportion 
of missing data. The IPW approach consistently resulted in 
worse RMSEs compared with the ML and MI approaches. 
Figure 3 RMSE of the estimated treatment coefficient using the observed missing data pattern.
Abbreviations: IPW, inverse probability weighting; MAR, missing at random; MI, multiple imputation; ML, maximum likelihood; RMSE, root mean square error.
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The difference between the performance of the IPW approach 
and of the ML and MI approaches was more pronounced 
for smaller sample sizes. The same patterns were observed 
when using the MAE as a performance measure (see the 
Supplementary materials). 
Figure 6 presents the SEs for the treatment effects. The 
ML and MI approaches produced SEs that were very similar 
to the true SEs. The IPW approach produced elevated SEs, 
particularly under scenarios with both higher proportions of 
missing data and smaller sample sizes.
Similar patterns for all three performance measures were 
observed for the three approaches for handling missing data under 
the “stronger MAR” scenario (see the Supplementary materials).
Further simulations added more PROM follow-up data 
(SF-12 and EQ-5D-3L) into the MI and IPW models. The 
MI approach introduced smaller RMSEs into the treatment 
effects compared with the ML approach when the original 
missing data pattern (a mixture of intermittent and monotone 
missingness) was maintained. The IPW approach intro-
duced similar RMSEs in this and the previous simulations 
( Figure 4). When considering a scenario with only monotone 
missingness, the differences in the RMSEs introduced by 
the MI approach decreased marginally, particularly for large 
proportions of participants with missing follow-up data 
( Figure 5), compared with intermittent missing data patterns. 
IPW produced greater errors than the other approaches.
The MAE in the estimated treatment effects was also used 
to measure the performance of the three approaches when 
handling missing data. The results for the MAE (shown in 
the Supplementary materials) were consistent with those 
presented above for the RMSE. Estimates of the SE of the 
treatment effects remained consistent across the simulation 
scenarios considered.
Discussion
This paper aimed at comparing the performance of the three 
approaches for analyzing longitudinal PROMs with some 
missing data: ML, MI, and IPW. These approaches are all 
well established and straightforward to implement using 
standard statistical software.
The simulation results obtained from ML and MI were 
very similar under MAR, when the MI model took into 
Figure 4 RMSE of the estimated treatment coefficient adding the SF-12 and EQ-5D-3L to the MI and IPW models.
Abbreviations: EQ-5D-3L, EuroQol 5 Dimension 3 Level questionnaire; IPW, inverse probability weighting; MAR, missing at random; MI, multiple imputation; ML, maximum 
likelihood; RMSE, root mean square error; SF-12, 12-Item Short Form Health Survey.
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Analyzing incomplete longitudinal PROMs data
account baseline data, data collected early in the trial, and 
the relevant outcome scores. These results agree with the 
existing literature.34,50 However, when the MI model included 
additional auxiliary variables collected over the follow-up 
period of the study, MI performed better than ML. This is an 
important finding as RCTs commonly collect information on 
a number of different PROMs, as well as clinical information 
such as clinical assessments, readmissions, and complica-
tions. This information should be used in MI models, where 
appropriate. Using auxiliary variables can also make the 
MAR assumption, on which all these three approaches rely, 
more plausible,38 particularly when some missing data are 
related to a change in health states.51 In such scenarios, MI 
should be favored over ML. 
The MI model including auxiliary variables performed 
slightly worse with monotone missing data than with inter-
mittently missing data. This finding emphasizes the impor-
tance of continued data collection and including all collected 
data in the analysis.
IPW performed notably worse than its comparators, 
in terms of both bias and variability around the estimates 
of the treatment effects. IPW potentially uses only a small 
subset of the observed outcome data. In line with the current 
literature, we do not recommend using IPW as implemented 
here to handle missing longitudinal PROM data in RCTs.52 
Some convergence issues were observed for the IPW models 
for small sample sizes, as the same statistical models were 
used across all simulation scenarios. Outside the context of a 
simulation study, models should be tailored to the data avail-
able and simplified for smaller sample sizes, as appropriate. 
The differences in the performance measures for the three 
approaches are relatively small. They lie within the measure-
ment error of the PROM and do not exceed its minimal impor-
tant difference, which have been estimated at 4 and 5 points, 
respectively.10 These differences are unlikely to be clinically 
meaningful. However, many trials are powered to detect small 
differences between treatment arms. For example, the KAT 
study was powered to detect a 1.5 point difference in the OKS 
for the patella resurfacing  comparison.40 Thus, even these 
moderate differences can affect trial conclusions; they can 
be used to derive guidance on which approach for handling 
missing data to be used. 
Figure 5 RMSE of the estimated treatment coefficient – considering dropouts only while also using the SF-12 and EQ-5D-3L as auxiliary variables in the MI and IPW models.
Abbreviations: EQ-5D-3L, EuroQol 5 Dimension 3 Level questionnaire; IPW, inverse probability weighting; MAR, missing at random; MI, multiple imputation; ML, maximum 
likelihood; RMSE, root mean square error; SF-12, 12-Item Short Form Health Survey.
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A limited number of missing data scenarios were consid-
ered, and the maximum sample sizes were restricted by the 
number of complete cases in the trial that this simulation 
study is based on. However, sample sizes ranging from 100 
to almost 1,000 participants were deemed representative of 
the vast majority of RCTs. 
Most of the simulations considered the same missing data 
pattern, a mixture of intermittent and monotone missing-
ness. Missing data patterns are likely to vary between trials 
and, to a smaller extent, between PROMs. Other patterns of 
missingness could have been investigated here. However, 
monotone and intermittently missing data are commonly 
observed in RCTs, and we believe that the patterns used, as 
well as the conclusions drawn, are generalizable to a large 
proportion of RCTs. 
The simulation scenarios that added auxiliary PROM data 
in the MI and IPW approaches assumed that these PROMs 
were completely observed, which may not have been realistic. 
However, most RCTs collect information on several PROMs, 
which are likely to have different completion rates. More 
resources may be spent on ensuring high completion rates 
for the primary or key secondary outcome measures, eg, 
through follow-ups by telephone. It is also possible that RCT 
participants are more inclined to complete shorter question-
naires or those they consider more relevant to themselves. 
Different follow-up schedules may be used for different 
PROMs, and those collected more frequently can be used to 
make inferences about missing data in other questionnaires. 
Information on clinical assessments, readmissions, additional 
treatment, or complications may be less prone to missing 
data and could be used in imputation models. In short, any 
available additional postrandomization information should 
be included in imputation models if deemed appropriate to 
reduce bias.
The ML, MI, and IPW approaches were implemented 
as described in the “Methods” section. These specifica-
tions were included in this simulation study as they are well 
established, commonly used by the statistical community, 
and easily implementable using standard statistical software. 
Other specifications of these models are possible, but were 
not considered here. IPW performed worse than ML and MI 
Figure 6 SE of the estimated treatment coefficient using the observed missing data pattern.
Abbreviations: IPW, inverse probability weighting; MAR, missing at random, MI, multiple imputation; ML, maximum likelihood; SE, standard error.
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Analyzing incomplete longitudinal PROMs data
here, possibly because the IPW approach implemented did 
not use data from participants with any missing follow-up 
data. Other implementations of IPW have been suggested, 
including a stratification approach to account for different 
missing data patterns, which may be due to differences in 
patient characteristics; however, this approach is only thought 
to be appropriate if the number of missing data patterns is 
small.26 Doubly robust IPW approaches,37 or IPW incor-
porating some imputations,27,31 have also been suggested 
as alternatives. However, as the implementations for these 
approaches are complex and not routinely available in stan-
dard statistical software, they did not match the criteria for 
methods compared here.
The simulation studies presented here are restricted to the 
KAT study and the OKS. Validation in other PROMs could 
be beneficial. However, the OKS shares characteristics with 
many composite-score PROMs: it is used as a continuous 
score, baseline variables have some predictive ability for 
the OKS at follow-up, and there is moderate correlation 
between the OKS and other PROMs collected at follow-up. 
The results of the simulations using the OKS are thus likely 
to be generalizable to many other PROMs.
This work did not consider the effect of MNAR mecha-
nisms or misspecifications of the analysis model on the 
performance of the three approaches. As misspecification 
and MNAR can occur in a number of ways, the effect of 
different misspecifications or different MNAR mechanisms 
may have very different effects on the performance of the 
three approaches for handling missing data in longitudinal 
data sets. We therefore avoided general statements about the 
performance of the investigated analysis approaches that 
may not be applicable to all MNAR and misspecification 
scenarios, which could lead to underestimating the bias intro-
duced through missing data. The effects of MNAR scenarios 
should be investigated for all analyses on incomplete data 
in appropriate sensitivity analyses, as recommended in the 
literature.29,51,53–55
Conclusion
This simulation study directly compared the performances 
of ML, MI, and IPW in handling incomplete PROM data in 
a longitudinally collected data set from an RCT. The IPW 
model performed worse than the ML and MI approaches, 
introducing greater RMSE and MAE. It should therefore 
not be used for the analysis of similar small RCT data sets, 
especially when some missing outcome data are observed 
for ≥30% of participants. 
ML and MI perform similarly under MAR when no 
additional follow-up data are available. However, if auxiliary 
PROMs have been more completely observed during follow-
up than the PROM of primary interest, or other postrandom-
ization data are available, then MI performs better and should 
be favored over non-imputation-based ML approaches. As 
both approaches assume an MAR mechanism, additional 
sensitivity analyses considering MNAR scenarios should be 
conducted to supplement the primary analysis.
Availability of data and materials
The data used for this simulation work were collected as 
part of the KAT study. As the authors obtained permission to 
use the data for prespecified analyses and simulation studies 
performed as part of Ines Rombach’s doctoral thesis, the data 
set cannot be made publicly available. Data requests should be 
directed to the trial coordinating office, the Health Services 
Research Unit at the University of Aberdeen. The simulation 
work was performed in Stata and is available from the cor-
responding author upon request. 
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